๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

P.39 Docetaxel plus epirubicin (DE) vs docetaxel plus capecitabine (DC) as 1st line treatment in patients with locally advanced and metastatic breast cancer: a subgroup analysis for elderly patients of a multicenter randomized phase III trial from the Hellenic Oncology Research Group (HORG)

โœ Scribed by Vamvakas, L.; Karampeazis, A.; Ardavanis, A.; Souglakos, I.; Kalbakis, K.; Vardakis, N.; Kouroussis, Ch.; Malamos, N.; Varthalitis, I.; Mavroudis, D.


Book ID
122752725
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
57 KB
Volume
64
Category
Article
ISSN
1040-8428

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


P.40 Oral vinorelbine and gemcitabine (o